Emerging Growth Equities, Ltd. Initiates Coverage Of Ampio Pharmaceuticals, Inc. (AMPE) With A BUY Rating And $14.00 Price Target |
October 11, 2013 | October 2013 Bond Updates |
KING OF PRUSSIA, Pa., Oct. 11, 2013 /PRNewswire/ -- Emerging Growth Equities, Ltd. initiates coverage of Ampio Pharmaceuticals, Inc. (NYSE: AMPE) with a BUY rating and a $14.00 price target. Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for metabolic disease, eye... |
View more at: http://www.prnewswire.com/news-releases/emerging-growth-equities-ltd-initiates-coverage-of-ampio-pharmaceuticals-inc-ampe-with-a-buy-rating-and-1400-price-target-227382071.html |
Related News |
|